The MLH1 Gene Colorectal Cancer Hereditary Nonpolyposis Type 2 Genetic Test is a specialized diagnostic tool aimed at identifying mutations in the MLH1 gene, which are strongly linked to Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Type 2, also known as Lynch Syndrome. This condition significantly elevates the risk of developing colorectal cancer, among other types of cancer, at a younger age than typically observed in the general population. The test involves analyzing the patient's DNA to detect any genetic alterations in the MLH1 gene that may predispose them to this hereditary cancer syndrome.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test is crucial for individuals with a family history of colorectal cancer or other Lynch Syndrome-associated cancers. Early detection through genetic testing can enable proactive surveillance and preventive measures, potentially reducing the cancer risk or detecting it at an earlier, more treatable stage.
The cost of the MLH1 Gene Colorectal Cancer Hereditary Nonpolyposis Type 2 Genetic Test at DNA Labs UAE is 4400 AED. This investment in health allows individuals and families to make informed decisions regarding their medical care and lifestyle choices, guided by a comprehensive understanding of their genetic risk factors.
The "PMS2 Gene Colorectal Cancer Hereditary Nonpolyposis Type 4 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the PMS2 gene, which are linked to Lynch syndrome or Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Type 4. Lynch syndrome is a condition that significantly increases an individual's risk of developing colorectal cancer, among other types of cancer, at a younger age than typically observed in the general population. The test is crucial for individuals with a family history of colorectal cancer or those who have been identified as at risk through initial screenings.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves analyzing the DNA to detect any harmful mutations in the PMS2 gene. The results can provide valuable information for risk assessment, allowing for personalized monitoring and preventive strategies to reduce the risk of cancer development.
The cost of the test is 4400 AED, reflecting the comprehensive nature of the genetic analysis and the expertise required to interpret the results. It's an important investment in personal health for those with a predisposition to Lynch syndrome, offering a proactive approach to managing and mitigating the risk of colorectal and other cancers.
The EPG5 Gene Vici Syndrome Genetic Test is a specialized diagnostic assessment available at DNA Labs UAE, aimed at identifying mutations in the EPG5 gene, which are associated with Vici Syndrome. Vici Syndrome is a rare, autosomal recessive disorder characterized by a spectrum of clinical features including agenesis of the corpus callosum, cataracts, cardiomyopathy, skin hypopigmentation, and combined immunodeficiency, among others. This genetic testing plays a crucial role in the early diagnosis and management of the syndrome, offering insights into potential treatments and interventions for affected individuals.
Conducted in the state-of-the-art facilities of DNA Labs UAE, the test requires a sample of the patient's DNA, usually obtained through a blood draw. The EPG5 Gene Vici Syndrome Genetic Test is meticulously designed to detect the presence of mutations in the EPG5 gene, thereby confirming or ruling out the diagnosis of Vici Syndrome.
The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the specialized technology employed in identifying the genetic mutations. For families and individuals facing the possibility of Vici Syndrome, this genetic test provides a critical pathway to understanding the condition, enabling informed decisions about care and management.
The ACTG2 Gene Visceral Myopathy Genetic Test is a specialized diagnostic procedure designed to identify mutations in the ACTG2 gene, which are associated with visceral myopathy. Visceral myopathy is a rare condition that affects the smooth muscles of the gastrointestinal tract, leading to severe digestive issues and complications. This genetic test is a critical tool for confirming the diagnosis, understanding the disease's progression, and guiding treatment decisions for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the ACTG2 gene to detect any genetic abnormalities that may contribute to the condition. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing techniques to identify mutations.
The cost of the ACTG2 Gene Visceral Myopathy Genetic Test is 4400 AED. While the price may seem high, the test provides invaluable insights into the genetic underpinnings of visceral myopathy, enabling targeted interventions and personalized care plans. For families and individuals facing the challenges of visceral myopathy, this genetic test represents a crucial step toward better management of the condition and improved quality of life.
The RAB3GAP1 gene plays a crucial role in the development and function of various cellular processes, including membrane trafficking and neurotransmitter release. Mutations in the RAB3GAP1 gene are associated with Warburg Micro Syndrome Type 1, a rare genetic disorder characterized by microcephaly, intellectual disability, eye abnormalities, and postnatal growth retardation. To diagnose this condition, genetic testing is available, specifically targeting the RAB3GAP1 gene to identify mutations responsible for the syndrome.
At DNA Labs UAE, individuals suspected of having Warburg Micro Syndrome Type 1 can undergo the RAB3GAP1 Gene Genetic Test. This test is meticulously designed to detect mutations in the RAB3GAP1 gene that are indicative of the syndrome, providing essential information for diagnosis and potential management of the condition. The test is priced at 4400 AED, reflecting the specialized analysis involved in identifying the genetic mutations associated with this rare disorder. Through this testing, families and healthcare providers can gain valuable insights into the condition, enabling informed decisions regarding care and support for affected individuals.
The RAB3GAP2 gene plays a crucial role in cellular processes, and mutations in this gene are associated with Warburg Micro Syndrome Type 2, a rare genetic disorder. This condition is characterized by developmental delays, microcephaly, eye abnormalities, and neurological issues. To diagnose this syndrome, a genetic test targeting the RAB3GAP2 gene is essential.
DNA Labs UAE offers a comprehensive genetic test for the RAB3GAP2 gene to identify mutations linked to Warburg Micro Syndrome Type 2. This test is a vital tool for families seeking a diagnosis for symptoms consistent with the syndrome, enabling them to understand the genetic underpinnings of the condition. The test is priced at 4400 AED, reflecting the specialized analysis involved in detecting mutations within the RAB3GAP2 gene. Through this testing, families and healthcare providers can make informed decisions about care and management for individuals with Warburg Micro Syndrome Type 2.
The DDX11 Gene Warsaw Breakage Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the DDX11 gene, which are associated with Warsaw Breakage Syndrome. This condition is a rare genetic disorder characterized by growth retardation, microcephaly, and chromosomal instability, leading to a variety of developmental and physical challenges in affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a patient's DNA sample, the test can detect specific mutations in the DDX11 gene that cause the syndrome, providing crucial information for accurate diagnosis and management of the condition.
Priced at 4400 AED, the test is an investment in understanding a patient's genetic makeup, potentially leading to targeted treatments and interventions that can improve quality of life for those affected by Warsaw Breakage Syndrome.
The EZH2 Gene Weaver Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the EZH2 gene, which are closely associated with Weaver Syndrome. This condition is a rare genetic disorder characterized by accelerated growth and development, distinctive facial features, and other physical abnormalities. The test plays a crucial role in the early identification and management of the syndrome, allowing for tailored medical and supportive care plans to be developed for affected individuals.
Conducted through a blood sample or cheek swab, the test examines the DNA for specific mutations in the EZH2 gene that are indicative of Weaver Syndrome. The process is carried out in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of the results.
The cost of the EZH2 Gene Weaver Syndrome Genetic Test is set at 4400 AED, reflecting the advanced technology and expertise required to accurately identify the gene mutations. This investment can be invaluable for families seeking answers to developmental concerns in their children, providing them with crucial information for medical and developmental intervention strategies.
The ARNT2 Gene Webb-Dattani Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the ARNT2 gene, which are linked to Webb-Dattani Syndrome. This syndrome is a rare genetic disorder characterized by a spectrum of symptoms, including developmental delays, growth hormone deficiency, and distinctive facial features. The test is critical for early diagnosis and management of the condition, enabling healthcare providers to devise appropriate treatment and intervention strategies.
Performed using a sample of the patient's DNA, this test scrutinizes the ARNT2 gene for any abnormalities that may indicate the presence of Webb-Dattani Syndrome. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the ARNT2 gene. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, patients can expect reliable results that are crucial for understanding their genetic health and making informed decisions about their medical care.
The LTBP2 Gene Weill-Marchesani Syndrome Type 3 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the LTBP2 gene, which are associated with Weill-Marchesani Syndrome Type 3 (WMS3). Weill-Marchesani Syndrome is a rare genetic disorder characterized by short stature, reduced joint flexibility, and eye abnormalities, among other symptoms. The LTBP2 gene plays a crucial role in the development and maintenance of the body's connective tissue, and mutations in this gene can lead to the manifestations of WMS3.
This genetic test is vital for individuals with a clinical diagnosis suggestive of Weill-Marchesani Syndrome or for those with a family history of the condition, as it can provide definitive genetic evidence of WMS3. Early diagnosis through genetic testing can significantly impact the management and treatment of the syndrome, allowing for personalized care plans and interventions to improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the LTBP2 Gene Weill-Marchesani Syndrome Type 3 Genetic Test is 4400 AED. This investment covers the genetic analysis and the comprehensive report that details the findings, providing a clear understanding of the individual's genetic status concerning the LTBP2 gene mutations.
